The Clinical and Laboratory Standards Institute (CLSI, formerly the NCCLS) have developed a reproducible broth microdilution procedure for the antifungal susceptibility testing of fi lamentous fungi (molds) (document M38-A2) [6] to different antifungal agents, including the echinocandins. However, testing mold is not generally performed in routine clinical microbiology laboratories because the CLSI methodology is laborious; the clinical laboratory needs easy, reliable and non-time consuming alternative methods for determining in vitro susceptibility of fi lamentous fungi to aid in the selection and monitoring of antifungal therapy. The Etest has been evaluated for testing azoles and amphotericin B against Aspergillus spp. and other molds [7][8][9][10] and more recently, for testing caspofungin against Aspergillus spp.
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[11]; a better correlation of in vitro -in vivo results was observed for Aspergillus isolates with caspofungin reduced susceptibility than those obtained by the CLSI broth microdilution method [12] . The Etest has not been evaluated for testing either Aspergillus spp. with micafungin or anidulafungin. The purpose of this study was to compare the susceptibility results of caspofungin, micafungin and anidulafungin for Aspergillus spp.
Introduction
Aspergillus spp. are ubiquitous opportunistic fi lamentous fungi that cause invasive infections in immunocompromised patients with high morbidity and mortality [1, 2] . Appropriate and early therapeutic intervention is critical in the management of these infections. In response to the emergence of the resistance of Aspergillus spp. to reference azole agents [3, 4] , other antifungal agents are available for the treatment and prevention of fungal infection, including the echinocandins. The echinocandins are a novel class of semisynthetic lipopeptide antifungal compounds with good in vitro activity against Aspergillus spp.; due to their limited toxicity profi le and minimal drug-drug interactions they are attractive new options for the treatment of invasive aspergillosis [5] .
that were obtained by both the Etest and the CLSI broth microdilution reference method.
Material and methods
A total of 67 Aspergillus isolates (21 A. fumigatus , 18 A. fl avus , 17 A. terreus , seven A. niger and four A. glaucus ) and 10 isolates of Fusarium spp. were recovered from clinical specimens received in Valme University Hospital (Seville, Spain) and the University Hospital La Fé (Valencia, Spain). Identifi cation of each strain was performed using conventional techniques and microscopic examination [13] . The mold isolates were maintained in sterile water and were subcultured onto potato dextrose agar (Difco) to ensure viability and purity. Stock inoculum suspensions were prepared recovering the conidia from 7-day-old cultures grown on potato dextrose agar (Difco). Stock suspensions were adjusted spectrophotometrically in saline to optical densities that ranged from 0.09-0.13 (80-82% transmittance) following CLSI guidelines [6] . Final inoculum sizes ranged from 0.4 ϫ 10 4 to 5 ϫ 10 4 CFU/ml as demonstrated by a quantitative colony count on Sabouraud dextrose agar [6] .
CLSI Broth microdilution method was performed according to CLSI guidelines (M38-A2 document) [6] . Caspofungin (Merck Research Laboratories, Rahway, NJ), micafungin (Astellas Pharma Inc., Deerfi eld, Ill.) and anidulafungin (Pfi zer Central Research, New York, NY) were provided as standard powders for the preparation of CLSI microdilution trays. Drug dilutions were prepared in sterile distilled water, except anidulafungin which was prepared in dimethyl sulfoxide, to yield the fi nal two-fold drug concentrations of 0.015-8 mg/l. MICs panels containing the diluted two-fold drug concentrations were stored at Ϫ70ºC until use. Microdilution trays were incubated at 35ºC and MEC was read after at 24 h. The MEC was defi ned as the lowest drug concentrations that produced growth of small, rounded, compact colonies compared to the hyphal growth observed in the growth control well by microscopy [6] .
Two Quality Control (QC) isolates: C. parapsilosis ATCC 22019, C. krusei ATCC 6258 and two reference strains: A. fumigatus ATCC 204305 and A. fl avus ATCC 204304 were included in each susceptibility test for quality control and assessment of reproducibility by both methods. Stock suspensions for the QC yeast isolates were prepared following CLSI guidelines for yeast testing (M27-A3 document) [14] . Growth and sterility controls (drug free) were included for each isolate tested.
Etest method was performed by following the manufacturer's instructions (AB BIODISK, Solna, Sweden); plates were inoculated in three directions on RPMI medium supplemented with 2% glucose, with a nontoxic cotton swab dipped in the undiluted mold stock inoculum suspensions (approximate concentration of 10 6 UFC/ml).
The inoculated agar was allowed to dry for 15-30 minutes and Etest strips were applied to the plate with a pair of forceps. The range of drug concentrations in Etest strips for caspofungin, micafungin and anidulafungin was 0.002-32 mg/l. The plates were incubated at 35ºC and MICs were read at 24 and 48 h at the lowest drug concentration at which the border of the elliptical inhibition intercepted the scale on the antifungal strip. Etest MICs were recorded at the lowest drug concentration at which the border of the inhibition ellipse intersected the scale on the plastic antifungal strip. Microcolonies inside the zone of inhibition (trailing growth) were ignored for MIC determination because their morphologies were similar to those observed at the MEC [11, 15] .
Data analysis
For each antifungal agent and method, MEC and MIC ranges and geometric means (GM) were obtained. Discrepancies between MECs and MICs end points of no more than two dilutions were used to calculate the percentages of agreement [11] . Etest MICs were elevated to the next twofold concentration that matched the drug dilution schema of the CLSI M38-A2 method to facilitate comparisons and presentation of results [11] . Table 1 summarizes the susceptibilities of the 67 Aspergillus strains and the 10 Fusarium strains to caspofungin, micafungin and anidulafungin by both methods; Etest MICs were read at 24 and 48 h. All CLSI caspofungin MECs were Յ0.25 mg/l (GM 0.06 mg/l) while Etest MICs were Յ1 mg/l (GM 0.03 mg/l) at 24 h. Although Etest MICs were high (Ͼ8 mg/l) at 48 h for some isolates, GM MICs were similar at both 24 and 48 h. Most of our anidulafungin and micafungin CLSI MECs and MICs were lower than those of caspofungin (Յ0.015 mg/l). There was more variability of Etest MIC results between 24 and 48 h for caspofungin than for the other two echinocandins. All Fusarium spp. isolates showed MEC and MIC values higher than 8 mg/l.
Results
The MICs for QC and reference strains were within the published ranges [14] and MECs by broth microdilution/ MICs by Etest method for the reference strains were Յ 0.015 mg/l for the three echinocandins. Trailing growth was observed by Etest for the three echinocandins, except for seven A. niger tested at 24 h; very clear and easy-to-read inhibition ellipses were observed. At 48 h of incubation trailing growth was more pronounced than at 24 h but in the same manner microcolonies inside the zone of inhibition were ignored to read the MICs. We didn't observe macrocolonies of Aspergillus spp. inside the inhibition ellipses read at 48 h for any of the three candins assessed.
A. niger . In our study, the agreement found for micafungin and anidulafungin (Table 2) was excellent for all Aspergillus species tested (100%). For Fusarium spp., the agreement was excellent, because all isolates were resistant to all echinocandins by both methods. Table 2 shows the percentages of agreement between 24 and 48 h Etest MICs and 24 h broth microdilution method for the three echinocandins. The overall agreement for caspofungin at 24 h was slightly better than at 48 h Etest MICs for all Aspergillus spp. tested except for Similar data for trailing growth were obtained by other authors using the agar diffusion method [11, 15, 16] . Since trailing growth was greater at 48 h for most Aspergillus species assessed, Etest end points would be easier to evaluate at 24 h of incubation.
In conclusion, based on the agreement of Etest with the CLSI method, the 24 h Etest method could be a suitable alternative to test the susceptibility of Aspergillus spp. to micafungin and anidulafungin, and for caspofungin it would be suitable for A. fumigatus. For Fusarium spp. both methods were useful in detecting the intrinsic resistance to these antifungal agents.
Although the Etest has shown better correlation of in vitro -in vivo results for a single isolate than the CLSI method, more studies are necessary to establish the real performance of Etest regarding reliability and its ability to identify potentially resistant isolates. Further, future evaluation should include isolates with reduced susceptibility to these three agents.
